Document Detail

JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism.
MedLine Citation:
PMID:  20797387     Owner:  NLM     Status:  MEDLINE    
β-Catenin is a central player of the Wnt signaling pathway that regulates cell-cell adhesion and may promote leukemia cell proliferation. We examined whether JS-K, an NO-donating prodrug, modulates the Wnt/β-catenin/TCF-4 signaling pathway in Jurkat T-Acute Lymphoblastic Leukemia cells. JS-K inhibited Jurkat T cell growth in a concentration and time-dependent manner. The IC(50)s for cell growth inhibition were 14±0.7 and 9±1.2μM at 24 and 48h, respectively. Treatment of the cells with JS-K for 24h, caused a dose-dependent increase in apoptosis from 16±3.3% at 10μM to 74.8±2% at 100μM and a decrease in proliferation. This growth inhibition was also due, in part, to alterations in the different phases of the cell cycle. JS-K exhibited a dose-dependent cytotoxicity as measured by LDH release at 24h. However, between 2 and 8h, LDH release was less than 20% for any indicated JS-K concentration. The β-catenin/TCF-4 transcriptional inhibitory activity was reduced by 32±8, 63±5, and 93±2% at 2, 10, and 25μM JS-K, respectively, based on luciferase reporter assays. JS-K reduced nuclear β-catenin and cyclin D1 protein levels, but cytosolic β-catenin expression did not change. Based on a time-course assay of S-nitrosylation of proteins by a biotin switch assay, S-nitrsolyation of nuclear β-catenin was determined to precede its degradation. A comparison of the S-nitrosylated nuclear β-catenin to the total nuclear β-catenin showed that β-catenin protein levels were degraded at 24h, while S-nitrosylation of β-catenin occurred earlier at 0-6h. The NO scavenger PTIO abrogated the JS-K mediated degradation of β-catenin demonstrating the need for NO.
Niharika Nath; Mitali Chattopadhyay; Liliya Pospishil; Lucyna Z Cieciura; Satindra Goswami; Ravinder Kodela; Joseph E Saavedra; Larry K Keefer; Khosrow Kashfi
Related Documents :
7892257 - Myoblast differentiation during mammalian somitogenesis is dependent upon a community e...
2039757 - Identification of aldosterone metabolites formed by a6 cells.
2541727 - 125i-iodopindolol binding to frog esophageal peptic cells. detection of amine uptake an...
19864107 - The wnt signaling pathway regulates nalm-16 b-cell precursor acute lymphoblastic leukem...
21520297 - Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell line...
469647 - Ultrastructural types of cell in adrenal cortical adenoma with primary aldosteronism.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural     Date:  2010-08-24
Journal Detail:
Title:  Biochemical pharmacology     Volume:  80     ISSN:  1873-2968     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-10-18     Completed Date:  2010-11-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1641-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Department of Physiology and Pharmacology, City University of New York Medical School, 138th Street and Convent Avenue, New York, NY 10031, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / drug effects,  physiology
Azo Compounds / pharmacology*
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / physiology*
Growth Inhibitors / pharmacology
Jurkat Cells
Nitric Oxide / physiology,  secretion*
Nitroso Compounds / pharmacology
Piperazines / pharmacology*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy,  metabolism*,  pathology
Prodrugs / pharmacology*
Signal Transduction / drug effects,  physiology*
Transcription Factors / physiology*
Wnt Proteins / physiology
beta Catenin / physiology*
Reg. No./Substance:
0/Azo Compounds; 0/Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; 0/Growth Inhibitors; 0/Nitroso Compounds; 0/O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate; 0/Piperazines; 0/Prodrugs; 0/TCF4 protein, human; 0/Transcription Factors; 0/Wnt Proteins; 0/beta Catenin; 10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterisation of the purified human sodium/iodide symporter reveals that the protein is mainly pr...
Next Document:  Influence of the flavonoids apigenin; kaempferol and quercetin on the function of organic anion tran...